Brief: Peptidream Inc - Astellas And Peptidream Enter Into Research Collaboration And License Agreement To Discover Novel Targeted Protein Degraders
25/07/2023 24:59
July 25 (Reuters) - Astellas Pharma Inc 4503.T :
* PEPTIDREAM INC - ASTELLAS AND PEPTIDREAM ENTER INTO RESEARCH COLLABORATION
AND
LICENSE AGREEMENT TO DISCOVER NOVEL TARGETED PROTEIN DEGRADERS
Source text for Eikon: ID:nTSsx806f6
Further company coverage: 4503.T
Recent news on PeptiDream
See all newsTable: Peptidream 6-MTH group results (IFRS)
Brief: Peptidream Inc. - Initiation Of Phase 1 Clinical Trial By Novartis Marks Milestone For Peptidream
Brief: PeptiDream Announces First Dosing Of 64cu-Pd-29,875 In Gastric Cancer Patients
Table: Peptidream -Q1 group results (IFRS)
Brief: Peptidream Announces The Initiation Of Phase 1 Clinical Trial By Its Collaboration Partner